Viatris (VTRS) Other Working Capital Changes (2019 - 2026)
Viatris (VTRS) posted Other Working Capital Changes of $141.0 million for Q2 2026, up 515.72% on a QoQ basis from $22.9 million in Q1 2026, and down 64.43% year-over-year from $396.4 million in Q2 2025.
Analysis
Viatris (VTRS) Other Working Capital Changes (2019 - 2026) Analysis & Trends
Viatris has reported Other Working Capital Changes for 8 years, with the latest figure at $141.0 million in Q2 2026.
- On a quarterly basis, Other Working Capital Changes fell 64.43% year-over-year to $141.0 million in Q2 2026; TTM through Jun 2026 was $224.0 million, a 60.24% decrease from a year earlier, with the FY2025 full-year figure at $633.7 million, up 320.78% from the prior year.
- Other Working Capital Changes was $141.0 million for Q2 2026 at Viatris, up from $22.9 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $483.5 million in Q4 2022, with the low at -$263.4 million in Q3 2023.
- Average Other Working Capital Changes over 5 years is $110.1 million, with a median of $121.2 million recorded in 2022.
- The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes sank 301.68% in 2023, then surged 708.98% in 2025.
- Over 5 years, Other Working Capital Changes stood at $483.5 million in 2022, then plunged by 45.83% to $261.9 million in 2023, then tumbled by 66.28% to $88.3 million in 2024, then slumped by 54.81% to $39.9 million in 2025, then soared by 253.38% to $141.0 million in 2026.
- The last three Other Working Capital Changes figures came in at $141.0 million (Q2 2026), $22.9 million (Q1 2026), and $39.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.53 Bn | 38.88 Bn | 2.15 Bn |
| 2 | Viatris | 19.14 Bn | 18.25 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.45 Bn | 5.33 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.33 Bn | 492.63 Mn | 2.10 Bn |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 400.20 Mn | 358.95 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.79 Mn | 178.79 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 141.00 Mn |
| Jun 30, 2026 | 141.00 Mn |
| Mar 31, 2026 | 22.90 Mn |
| Mar 31, 2026 | 22.90 Mn |
| Dec 31, 2025 | 39.90 Mn |
| Dec 31, 2025 | 39.90 Mn |
| Sep 30, 2025 | 20.20 Mn |
| Sep 30, 2025 | 20.20 Mn |
| Jun 30, 2025 | 396.40 Mn |
| Jun 30, 2025 | 396.40 Mn |
| Mar 31, 2025 | 177.20 Mn |
| Mar 31, 2025 | 177.20 Mn |
| Dec 31, 2024 | 88.30 Mn |
| Dec 31, 2024 | 88.30 Mn |
| Sep 30, 2024 | -98.50 Mn |
| Sep 30, 2024 | -98.50 Mn |
| Jun 30, 2024 | 49.00 Mn |
| Jun 30, 2024 | 49.00 Mn |
| Mar 31, 2024 | 111.80 Mn |
| Mar 31, 2024 | 111.80 Mn |